Exos Asset Management’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,990
Closed -$32K 789
2021
Q2
$32K Buy
+13,990
New +$31.4K 0.02% 587

Other funds holding ATIP.WS

Exos Asset Management's ATIP.WS Position: Q3 2021 in Review

Exos Asset Management sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q3 2021, closing a stake of 13,990 shares — an estimated $32K sold.

Exos Asset Management first reported a position in ATIP.WS in Q2 2021 and held it in 1 quarter. The position peaked at $32K in Q2 2021. 20 funds tracked by Wall St. Rank hold ATIP.WS as of Q3 2021.

  • Exos Asset Management reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 13,990 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $32K.
  • Exos Asset Management first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • Exos Asset Management's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $32K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.